Sign in
CompletedPhase 4

MyKid-study: a study to examine the effect and safety of an injection of Mydrane® into the eye of children who will undergo cataract surgery

Key facts

Who runs it
Antwerp University Hospital
Where
Belgium1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 4
People taking part
40 people enrolled
Started
1 Jul 2023
Ended
17 Sept 2025
Type of study
Interventional
Record updated
28 November 2023

Who can take part

Age
Up to 17 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Children aged 8 weeks to 17 years old who are scheduled for surgical cataract repair of one or both eyes

Who cannot take part

  • patients who previously had cataract surgery of one eye within this study and receive surgery of the contralateral eye on a different day
  • Patients with a reported allergy for one of the components of Mydrane®
  • Patients younger than 8 weeks
  • Patients who are pregnant. Girls of childbearing age will be tested for pregnancy with urinary analysis (hCG) at the time of inclusion

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Evaluation of the efficacy and safety of the use of Mydrane in children

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
MyKid-study: efficacy and systemic side effects of intracameral Mydrane® injections in children undergoing cataract surgery.
Record updated
28 November 2023